A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia

Malignant Hyperthermia Clinical Trial

Official title:
A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia

Status Withdrawn

Clinical Trial Summary

The purpose of the study is to develop methods to identify predictors of Malignant Hyperthermia.

Clinical Trial Description

The current study will use the combination of electronic medical records and genomic information in samples of persons who have exhibited signs of Malignant Hyperthermia (MH) or have family history or high risk of MH to see if risk factors can be identified. These will be compared with control samples of children who have been exposed to the same agents which could induce MH, yet showed no signs of the disorder. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02561598
Study type	Observational
Source	Children's Hospital Medical Center, Cincinnati
Contact
Status	Withdrawn
Phase
Start date	May 2023
Completion date	May 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05036148` - Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia
Withdrawn	`NCT01624558` - Effectiveness of Carbon Filters to Reduce the Anesthetic Gas Concentration in an Anesthetized Patient	N/A
Recruiting	`NCT04474860` - Gene Mutation Spectrum of Malignant Hyperthermia in China
Recruiting	`NCT05402839` - Screening of Malignant Hyperthermia Susceptible Individuals
Active, not recruiting	`NCT03964870` - Spanish Registry of RYR1 and CACNA1S Polymorphisms
Recruiting	`NCT04610619` - Multisystem Features of Malignant Hyperthermia or Rhabdomyolysis Related to RYR1 Variants
Terminated	`NCT02964481` - Malignant Hyperthermia Registry and Genetic Testing